Our results revealed that COL3A1, SDC2 and FN1 are dramatically enriched in the ECM-receptor interaction pathway, which may play a key role in the process of tumor development and bone metastasis of prostate cancer. The gene discussed is SDC2; the disease is prostate carcinoma.